Survey: Life Sciences lagging behind in AI development

The Pistoia Alliance has released results of a survey that found that 72 per cent of science professionals believe their sector is lagging behind other industries in the development of AI. “Spaces to virtually collaborate, like our Centre of Excellence, will become even more critical as political and social shifts – from Brexit to changes to US immigration laws – impact how scientists share knowledge and ideas. AI is poised to have a radical impact on life sciences and healthcare, but the industry must give researchers the best chance of success.”

Survey shows how AI Could Revolutionize Life Sciences

Some 44 per cent of life science professionals are using or experimenting with AI and deep learning, while 94 per cent expect an increase in use of machine learning within two years. These are findings from a survey carried out by the Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D. “Our survey data shows that while life science professionals are already exploring how AI, ML and NLP can be used – there are clear gaps in the knowledge, data, and skills, which will enable more pharma and biotech companies to achieve tangible results from AI.”